Qube Research & Technologies (QRT)’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Qube Research & Technologies (QRT)'s RGEN Position: Q2 2024 in Review
Qube Research & Technologies (QRT) sold out of Repligen (RGEN) in Q2 2024, closing a stake of 3,377 shares — an estimated $621K sold.
Qube Research & Technologies (QRT) first reported a position in RGEN in Q2 2020 and held it in 13 quarters. The position peaked at $8M in Q4 2021. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.
- Qube Research & Technologies (QRT) reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 3,377 Repligen shares in Q2 2024, an estimated $621K.
- Qube Research & Technologies (QRT) first reported a position in Repligen in Q2 2020 and held it in 13 quarters.
- Qube Research & Technologies (QRT)'s Repligen position peaked at $8M in Q4 2021.
- 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.